Need to ‘Step Up the Pace’ to Reach Global 2020 UNAIDS Goals

GLASGOW, United Kingdom – Although several countries are close to meeting the UNAIDS HIV targets for 2020, global progress is just past the halfway point, according to Julio Montaner, MD, director of the BC Center for Excellence in HIV/AIDS in Vancouver, British Columbia, Canada.

“This is really very problematic; 2020 is around the corner, and I’m afraid that if we don’t step up the pace, we’re not going to get there,” he said here at HIV Drug Therapy 2016.

The 90-90-90 plan states that by 2020, 90% of those infected with HIV should know their status, 90% of those (81% of the total) should be receiving antiretroviral therapy, and 90% of those (73% of the total) should be virally suppressed. If these targets are achieved, AIDS could be eliminated as a public health threat by 2030, according to UNAIDS.

Although there are pockets of success, the current totals are not 90%, 81%, and 73%, they are 57%, 46%, and 38%, Dr Montaner reported.

In British Columbia, Dr Montaner’s home base, there was political support for the treatment for all people infected with HIV well before guidelines recommended it, he explained. As a result, the incidence of HIV, which had been rising rapidly before 1996, declined significantly.

Scroll to Top

Canada Post has provided notification of restarting their operations on December 17, 2024. As Canada Post ramps up and stabilizes their services, the BC-CfE will continue the following measures on an interim basis to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory will utilize private courier for delivery of outgoing reports and documents. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy will utilize private courier for delivery of medications. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)